Gsk Share Discussion Threads

[tradermichael] 14/1/2020 07:57

GlaxoSmithKline has made innovation its top priority as the drugmaker seeks to land federal approval of six drugs within the next 12 months, CEO Emma Walmsley told CNBC on Monday.

[toffeeman] 13/1/2020 12:05

Looks like a good short trade at 1830

[tradermichael] 13/1/2020 09:56

1.00000 GBP = 1.29756 USD

[grahamburn] 12/1/2020 17:19

Useful write up on Emma Walmsley's policies in full page article in Sunday Times Business News today.

[keyno] 12/1/2020 11:13

As long as our hosts allow this kind of thing to continue it will ................ waste of space.

[crossing_the_rubicon] 12/1/2020 09:59

Always dubious when a tweeter has protected their account.

"Only confirmed followers have access to @smallcappick's Tweets and complete profile. Click the "Follow" button to send a follow request."

[ianood] 12/1/2020 09:33

Stocks - The link is protected and can't be opened? Please can you advise the content?

[garycook] 12/1/2020 02:56

Woodford was only for Woodford.If it was investigated,I believe he was being paid big fee,s for investing in these unlisted company,s,with investors fund money.He did not care about investors,only himself.Where as he invested his own money.I think not in unlisted companies that,s for sure ?

[dr biotech] 11/1/2020 19:33

The WPCT threads went into some detail about this. The areas which looked most dodgy were the guernsey listings to get round the percentage of unlisteds, and the non declaration that he sold a lot of his holding in WPCT without mentioning it as he apparently wasnt a PDMR. HL also have questions to answer. I'm in the process of closing my HL account partially because of it. The £350 yearly platform fees is the main reason.

Unfortunately his huge premier league remuneration for his amateur stock picking wasnt illegal.

[ianood] 11/1/2020 18:02

Dr B - my sentiments entirely, however, unfortunately the FCA don't insist on funds having an Investment/Trading Book Policy Statement or on their individual company and sector exposures being adhered to. Let alone an acceptable revaluation methodology which should have been rigorously monitored. These requirements, which are made on banks, would have saved joe public and also exposed him for the charlatan that he really was. I feel sorry for the poor investors who fell foul of his ego and p*ss poor regulatory attention to detail. Surely he has to be culpable in respect of his movement away from the initial Investment Terms of the Funds which appears also to have been ignored?

[panshanger1] 11/1/2020 11:39

Seemed to recall he had a big weighting in Astra Zeneca too - should have held on to that as well!!

[dr biotech] 11/1/2020 09:13

Woodford should have stayed with GSK and not bought into the early stage biotiddlers that few really understand. At one point I had 25% of my portfolio in his various funds. Fortunately I sold out when he took such a large holding in prothena and realised he’d lost the plot. I’m really surprised the fca aren’t after him with some of the things he did.

Your dividend TM is worth more than my entire holding. GSK isn’t one of my top 10 though.

[tradermichael] 10/1/2020 10:13

I'm expecting some action ahead of this:
5 February 2020
(announcement of Q4 2019 results)

[sicker] 09/1/2020 10:24

I can afford Black Forrest gateau to-day :-)

[tradermichael] 09/1/2020 10:08

Wow, something was driving the price this morning. Thought it was all those dividends being reinvested (mine is for some cakes and some more GSK shares when the price relaxes a bit ….. ;0) )

[philanderer] 09/1/2020 10:05

Morning everyone.. FWIW


+++ SOCGEN KEEPS GLAXOSMITHKLINE 'BUY' RATING - PRICE TARGET 2300 (2200) PENCE +++

[tradermichael] 09/1/2020 10:01

LOL …. ;0)

[badtime] 09/1/2020 09:57

Cakes are on you then

[tradermichael] 09/1/2020 09:52

Yes, I received £7673 in my AJ Bell accounts this morning …. ;0)

[gateside] 09/1/2020 08:39

First GSK dividend of the year is paid today

[tradermichael] 08/1/2020 15:23

Deborah Waterhouse, CEO of ViiV Healthcare, to join GSK Corporate Executive Team (CET)


Prior to joining ViiV Healthcare as its CEO, Waterhouse spent more than 20 years climbing the GSK corporate ladder. Early in her career, she had stints in sales and marketing, and she spent four years in R&D working on early-target product profiles and commercial analytics around new assets. “I even did a two-year rotation through HR,” she shares. “After all, the biopharmaceutical industry is here to serve patients, and the best way to do that is by having the right people in the right roles, so you can focus on unlocking their potential.” Following these London- based positions, she took on the role of country manager for Australia and New Zealand. Next it was back to the U.K. as head of central and eastern Europe, a 22-country responsibility. Then she spent three years in Philadelphia, first as the business unit head of GSK’s U.S. vaccine business, then heading up the company’s U.S. primary care business.

[tradermichael] 08/1/2020 09:57

Final year end divi xd is 20 Feb 20. A lovely 23p available for buyers till then ….. ;0)

[abdullla] 08/1/2020 09:34

SP back to divi buying levels or even lower